Össur hf. reaffirmed financial guidance for the year 2023. For the year, the financial guidance is unchanged or 7-8% organic sales growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.4 DKK | -0.34% |
|
+4.63% | +7.10% |
23/04 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
23/04 | Embla Medical hf. Provides Earnings Guidance for the Year 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.10% | 1.81B | |
-15.27% | 20.12B | |
+1.42% | 18.42B | |
-0.07% | 9.34B | |
-26.80% | 1.85B | |
+3.27% | 1.33B | |
-1.40% | 512M | |
0.00% | 344M | |
+90.14% | 220M | |
+25.74% | 105M |
- Stock Market
- Equities
- EMBLA Stock
- News Embla Medical hf.
- Össur hf. Reaffirms Financial Guidance for the Year 2023